Anticancer Effect of Salvia plebeia and Its Active Compound by Improving T-Cell Activity via Blockade of PD-1/PD-L1 Interaction in Humanized PD-1 Mouse Model

Immune checkpoint inhibitors, increasingly used to treat malignant tumors, are revolutionizing cancer treatment by improving the patient survival expectations. Despite the high antitumor efficacy of antibody therapeutics that bind to PD-1/PD-L1, study on small molecule-based PD-1/PD-L1 inhibitors is...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jang-Gi, Kim, Young Soo, Kim, Ji Hye, Kim, Tae In, Li, Wei, Oh, Tae Woo, Jeon, Chang Hyun, Kim, Su Jin, Chung, Hwan-Suck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674495/
https://www.ncbi.nlm.nih.gov/pubmed/33224152
http://dx.doi.org/10.3389/fimmu.2020.598556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674495/
https://www.ncbi.nlm.nih.gov/pubmed/33224152
http://dx.doi.org/10.3389/fimmu.2020.598556

Ejemplares similares